Literature DB >> 24388532

Severe thrombocytopenia induced by second exposure to trastuzumab can be alleviated by prolonging the interval between treatments.

Rui-chao Zeng1, Xuan-xuan Dai1, Fei-yan Xie1, En-dong Chen1, Jin-miao Qu1, Xiao-qu Hu2.   

Abstract

Entities:  

Keywords:  Breast carcinoma; Thrombocytopenia; Trastuzumab

Mesh：

Substances：

Year:  2013        PMID： 24388532     DOI： 10.1016/j.clbc.2013.11.004

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN： 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  2 in total

1.  Trastuzumab Associated With Recurrent Severe Thrombocytopenia and Successful Use of Pertuzumab Monotherapy.

Authors:  Mallorie L Huff; Joshua A Kalter; Ramona E Chase; Ranju Gupta
Journal:  Cureus       Date:  2022-01-30

2.  Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer.

Authors:  Yuko Takano; Satoshi Furune; Yuki Miyai; Sachi Morita; Megumi Inoue; Tomoya Shimokata; Mihoko Sugishita; Ayako Mitsuma; Osamu Maeda; Yuichi Ando
Journal:  Int Cancer Conf J       Date:  2021-11-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.